| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |